Meilleure Health International Industry Group 2327.HK · HKD
Industrials · HKEX · 🇭🇰 Hong Kong
0.17
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Meilleure Health International Industry Group
Its shares trade on HKEX under the ticker 2327.HK. It has been listed since 14 October 2003. In the fiscal year to 31 December 2025, it reported revenue of HK$36.5m and net income of HK$38.0m. At that date it held total assets of HK$1.82bn and shareholders' equity of HK$1.25bn.
Meilleure Health International Industry Group Ltd. engages in the research and sale of medicine and health care products, development of chemical and biological products, and multiple industrial investment and holdings. The company employs 116 full-time employees The company went IPO on 2003-10-14. The firm operates its business through five segments. The Trading of Health Care Products, Chemical Materials and Building Materials segment is engaged in the trading of health care products, chemical materials and building materials. The Research and Development segment is engaged in the research and development of chemical and biological products. The Investment and Treasury Function segment is engaged in investment holding and treasury function. The Consultancy and Agency Business segment is engaged in the provision of property agency and consultancy service. The Property Development segment is engaged in the development of residential properties.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Trading Companies & Distributors
- Listed since
- 14 Oct 2003
- Employees
- 116
- Website
- meilleure.com.cn ↗
Leadership
Pay as last reported
- Mr. Wentao ZengExecutive Co-Chairman of the Board, since 2017HK$594,000
- Mr. Xuzhou ZhouExecutive Co-Chairman of the Board, since 2013HK$800,000
- Ms. Wen Chuan ZhouExecutive Vice Chairman of the Board, Chief Executive Officer, since 2013HK$1.9m
- Mr. Shu Pai LiChief Financial Officer, Company Secretary
- Mr. Zhenhua MaoNon-Executive DirectorHK$180,000
- Prof. Chi Wai ChauIndependent Non-Executive DirectorHK$180,000
- Dr. Shi ChenNon-Executive Independent Director
- Mr. Peng WuNon-Executive Independent DirectorHK$120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Meilleure Health International Industry Group Ltd benefits from a wide range of innovative healthcare products and services. The diverse product portfolio allows the company to cater to various customer needs and capture market share across different segments of the industry.
- The company has established a strong market presence both domestically and internationally. Its brand recognition, coupled with a robust distribution network, enables Meilleure Health International Industry Group Ltd to effectively reach its target customers and penetrate new markets.
- The company is led by an experienced management team with a deep understanding of the healthcare industry. Their expertise and strategic decision-making capabilities contribute to the company's overall success and ability to adapt to changing market dynamics.
Weaknesses
- Meilleure Health International Industry Group Ltd heavily relies on external suppliers for raw materials and components needed for its products. This dependency exposes the company to potential supply chain disruptions and pricing fluctuations, which may impact its production and profitability.
- The company's geographic coverage is relatively limited compared to some of its competitors. This can pose challenges in terms of reaching a wider customer base and expanding into new markets where competitors already have a strong presence.
Opportunities
- The healthcare industry is experiencing significant growth worldwide, driven by factors such as an aging population, technological advancements, and increased healthcare expenditure. Meilleure Health International Industry Group Ltd can capitalize on this trend by introducing new products and expanding its market reach in emerging economies.
- The company can explore opportunities for strategic partnerships and acquisitions to enhance its product offerings, expand its customer base, and gain access to new technologies or markets. Collaborations with research institutions or healthcare providers can also strengthen Meilleure Health International Industry Group Ltd's position in the industry.
Threats
- The healthcare industry is highly competitive, with many established players and emerging startups vying for market share. Meilleure Health International Industry Group Ltd faces the risk of intense competition, which may impact its pricing power, market share, and overall profitability.
- Changing regulations and compliance requirements in the healthcare sector can pose challenges for Meilleure Health International Industry Group Ltd. The company needs to closely monitor and adapt to these regulatory changes to ensure legal compliance and avoid potential penalties or reputational damage.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.